Correction

Clopidogrel for the Prevention of Atherothrombotic Events

N Engl J Med 2006; 355:1076September 7, 2006

Article

Clopidogrel for the Prevention of Atherothrombotic Events (Correspondence, N Engl J Med 2006:355;418 - 421) . On page 420, the second line of the reply letter by Topol should have read, “there was a benefit of dual antiplatelet therapy with respect to the reduction in the rate of nonfatal stroke (1.9 percent in the group given aspirin and clopidogrel vs. 2.4 percent in the group given aspirin and placebo, P=0.03),” not “(2.4 percent in the group given aspirin and clopidogrel vs. 1.9 percent in the group given aspirin and placebo, P=0.03),” as printed.